Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jill R. Schofield"'
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 14, Iss , Pp 105-109 (2019)
Purpose: Acute macular neuroretinopathy has been shown to be due to ischemia of the deep capillary retinal plexus and most cases occur in young women; we hypothesized that there may be an association with antiphospholipid antibodies. Observations: We
Externí odkaz:
https://doaj.org/article/05d6d55446af4ed2ad342ffb9e813012
Autor:
Jill R. Schofield, Kamal R. Chémali
Publikováno v:
American Journal of Therapeutics. 26:e570-e582
Background Intravenous immunoglobulin (IVIG) has recognized efficacy in autoimmune peripheral nerve disorders, but there has been limited study of the use of IVIG in autoimmune dysautonomias. Study question To determine the efficacy and safety of IVI
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 14, Iss, Pp 105-109 (2019)
American Journal of Ophthalmology Case Reports
American Journal of Ophthalmology Case Reports
Purpose: Acute macular neuroretinopathy has been shown to be due to ischemia of the deep capillary retinal plexus and most cases occur in young women; we hypothesized that there may be an association with antiphospholipid antibodies. Observations: We
Autor:
Jill R. Schofield, Lawrence B. Afrin
Publikováno v:
The American Journal of the Medical Sciences. 357:507-511
Mast cell activation syndrome (MCAS) is a complex disorder hallmarked by chronic multisystem inflammatory, allergic and growth dystrophic phenomena caused by inappropriate mast cell activation. MCAS has been estimated to affect as many as 17% of the
Autor:
Jill R. Schofield
Publikováno v:
Eur J Case Rep Intern Med
European Journal of Case Reports in Internal Medicine (2021)
European Journal of Case Reports in Internal Medicine (2021)
This is the first case report of a patient with post-COVID-19 postural orthostatic tachycardia syndrome (POTS) with multiple persistent antiphospholipid antibody (aPL)-positivity more than a year after illness onset who also meets Global Consensus-2
Publikováno v:
Lupus. 30(4)
Objective It has been reported that patients with antiphospholipid antibodies (aPL) and refractory migraine may experience symptomatic improvement with antithrombotic therapy, but this phenomenon has not been well studied. This study was undertaken t
Autor:
Jill R. Cuni, Ilene S. Ruhoy, Emma J. Reinhold, Stephanie J. Kratzer, Peter C. Rowe, Ariana D. Buchanan, Mark Westaway, Laurie Radovsky, William Patrick Davey, Andrew J. Maxwell, William A. Robinson, Martina Wengenroth, Kimberly J. Hindman, Jill R. Schofield, David L. Kaufman, Mindy S. Marantz, David A. Schlosser, Dahra D. Perkins, Dwight L. McKee, Jill B Brook, E. Scott Rosenbloom, Leonard B. Weinstock, Laura A. Pace, Alena G. Guggenheim, Sonia A. Rapaport, Mark Renneker, Gerhard J. Molderings, Linda S. Bluestein, Martin S. Dubravec, Tania T. Dempsey, Joseph H. Brewer, Shanda R. Dorff, Aaron M. Roland, Mary B. Ackerley, Shijun Cindy Xi, Janet E. Settle, Bruce Hoffman, Lawrence B. Afrin, Kelly K. McCann, David S. Saperstein, Laurie Menk Otto, Theodore M. Lee, Mary S. Raleigh
Publikováno v:
Diagnosis (Berlin, Germany)References. 8(2)
The concept that disease rooted principally in chronic aberrant constitutive and reactive activation of mast cells (MCs), without the gross MC neoplasia in mastocytosis, first emerged in the 1980s, but only in the last decade has recognition of “ma
Autor:
Jill R. Schofield, Kamal R. Chémali
Publikováno v:
European neurology. 80(5-6)
Intravenous immunoglobulin therapy is FDA approved for the immune-mediated peripheral nerve disorders Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy. Immunoglobulin therapy has been used in
Publikováno v:
Clinical pediatrics. 57(5)
Autor:
Jill R Schofield
Publikováno v:
Immunologic research. 65(2)
Autonomic disorders have previously been described in association with the antiphospholipid syndrome. The present study aimed to determine the clinical phenotype of patients in whom autonomic dysfunction was the initial manifestation of the antiphosp